As revenues fall in diabetes treatments, has the industry found a new revenue driver in weight-loss treatments ... the FDA for type 2 diabetes in May 2022, and, ahead of any additional approval ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says. GLP-1 weight ...

The new weight-loss drugs have created “a hope and optimism ... by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported a higher treatment ...

with these new uses, around a fifth of Medicare’s population, some 16m patients, could have access by 2026. At the same time, competition is likely to make weight-loss drugs both better and cheaper.

There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Oct 30 (Reuters) - The lowest dose of Novo Nordisk's (NOVOb.CO), opens new tab weight-loss drug ... on the U.S. Food and Drug Administration's shortage list since early 2022.

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims. A review by ...

The NHS's latest Health Survey for England shows in 2022, 29% of adults in England ... Streeting said he was expecting "demand" for new weight-loss drugs to outstrip NHS supplies.